TalkHER.org

For decades, birth control has basically been treated like a woman’s problem.

You take the pill. You get the IUD. You remember when to take your medication. You deal with the side effects. You track your cycle. You make the appointment. You worry about pregnancy.

And then, somehow, if a pregnancy happens, the conversation can still turn into, “Well, was she on birth control?”

So when researchers started seriously developing new forms of male contraception, a lot of women had one very understandable reaction.

Oh. So now we are sharing the responsibility?

And before anyone gets too excited, no, men cannot walk into CVS tomorrow and pick up a male birth control pill. These products are still experimental and are being tested in clinical trials.

But there are several different approaches being studied right now, and honestly, some of them are pretty fascinating.

The Male Birth Control Pill

One of the biggest names right now is YCT-529, an experimental pill being developed as a nonhormonal form of male contraception.

And this one is particularly interesting because it does not work by simply lowering testosterone.

YCT-529 targets a protein called retinoic acid receptor alpha, or RAR-alpha. This protein is involved in sperm production. Researchers found that interfering with this pathway can suppress sperm production while potentially leaving testosterone and other hormonal functions intact.

In animal studies, daily YCT-529 reduced sperm production and fertility, and the effects were reversible after treatment stopped. The drug has also moved into human clinical trials, which is a pretty big deal because we are no longer talking only about something that worked in a laboratory or in mice. Researchers are now studying how it behaves in actual human bodies.

But before we start planning the male birth control aisle at Walgreens, there is a reality check.

YCT-529 is still being studied. Early human research is encouraging, but researchers need much more information about long-term safety, effectiveness, fertility recovery and side effects before something like this could become an approved contraceptive.

Basically, the pill is promising.

It is not ready for your boyfriend to casually pick up yet.

Then There Is the Gel

This is where male birth control gets even more interesting.

Researchers have also been developing a hormonal contraceptive gel called NES/T.

Unlike YCT-529, this one is hormonal.

The gel combines testosterone with a progestin called segesterone acetate, also known as Nestorone. The goal is to suppress the hormones that stimulate sperm production while providing enough testosterone to maintain normal testosterone-dependent functions.

Think of it as essentially telling the reproductive system, “We are taking a little break from making sperm.”

The gel is applied to the skin rather than swallowed as a pill.

Research has shown that this approach can significantly suppress sperm production in many participants, but it has also shown us something very important about male contraception.

Getting sperm production low enough to reliably prevent pregnancy is not necessarily the hardest part.

Getting there consistently, keeping the method tolerable and making sure fertility returns after stopping are all major pieces of the puzzle.

And yes, researchers have to study the side effects too.

Because apparently once men are involved, we suddenly remember that medications should actually be studied for how they affect people’s entire bodies.

Funny how that works.

And Then There Is ADAM

Now this one sounds like something straight out of a science fiction movie.

It is called ADAM, and it is being developed by Contraline.

Instead of taking a pill or rubbing gel onto the skin, ADAM involves placing a biodegradable hydrogel into the vas deferens, the tubes that carry sperm from the testes.

The idea is to create a physical barrier that prevents sperm from traveling through the reproductive tract.

Semen can still be produced, but sperm are blocked from making the journey.

Think of it like putting a temporary roadblock on the sperm highway.

And unlike a traditional vasectomy, ADAM is designed to be nonpermanent because the hydrogel is designed to break down over time.

That is the part that has gotten people really interested.

Early clinical research has shown promising results, including participants remaining sperm-free for extended periods. However, researchers are still studying how reliably fertility can be restored and how safe the method is over the long term.

And this is an important distinction.

Designed to be reversible does not automatically mean proven reversible.

That is something we need to keep watching as the research develops.

So Is ADAM Basically a Male IUD?

Honestly, that comparison makes sense.

An IUD sits inside the uterus and provides contraception without requiring someone to remember a pill every day.

ADAM is trying to create a somewhat similar concept for male contraception by placing a contraceptive material inside the reproductive system.

But the biology is completely different.

An IUD works inside the uterus.

ADAM works inside the vas deferens.

So calling it a “male IUD” is a useful way to picture the concept, but it is not literally the same thing.

And There Is Another One Called NLS-133

Researchers are not stopping with pills and long-term implants.

Next Life Sciences is studying NLS-133, another experimental nonhormonal male contraceptive designed to work on demand.

The current clinical trial is specifically investigating whether NLS-133 could provide temporary contraception without requiring continuous hormonal treatment. The study is registered on ClinicalTrials.gov and was listed as recruiting in its February 2026 update.

That could be a pretty major shift if the approach eventually works.

Imagine having a contraceptive option that does not require taking something every single day and does not involve permanently altering fertility.

That is exactly the kind of flexibility researchers are trying to create.

Why Does Male Birth Control Take So Long?

Here is where the science gets complicated.

Women typically release one egg during a menstrual cycle.

Men produce sperm constantly.

And not just a little bit of sperm.

The testes can produce millions of sperm every day.

So researchers are basically trying to stop an entire production line rather than preventing one egg from being released.

They also need the method to be effective enough to actually prevent pregnancy, safe enough to use and reversible enough that fertility can return when someone wants to have children.

That is a lot of boxes to check.

But There Is Another Conversation We Need to Have

Male birth control is exciting because it could change more than contraception.

It could change responsibility.

For generations, women have been expected to carry a huge portion of the responsibility for preventing pregnancy.

And that responsibility can come with a physical cost.

Hormonal birth control can be incredibly helpful for many women, but it can also come with side effects. IUD insertion can be painful. Some women cannot use certain hormonal methods. Some experience changes in mood, bleeding patterns or other symptoms.

That does not mean hormonal birth control is bad.

It means having more options is better.

If a couple has another safe and effective contraceptive option available, they have another choice.

And women should not have to be the only people making that choice.

So When Can Men Actually Get Birth Control?

Not yet.

That is probably the least exciting sentence in this entire article, but it is important.

YCT-529 is still in clinical development.

ADAM is still being studied.

NES/T has undergone clinical research but is not an approved contraceptive product.

NLS-133 is also still being investigated.

None of these should be treated as something you can buy online and safely start using on your own.

Clinical trials exist for a reason.

Scientists need to know how effective these methods are, what side effects they cause, whether those effects are reversible and how well they work in real-world conditions.

The Bigger Picture

What I actually love about this research is that it challenges the idea that contraception automatically belongs in the woman’s department.

Pregnancy takes two people.

Preventing pregnancy should not automatically become one person’s responsibility.

Maybe the future of contraception is not about finding one perfect method.

Maybe it is about having more choices.

Maybe some couples will choose an IUD.

Some will use condoms.

Some will choose hormonal contraception.

Some may eventually choose a male pill.

Some may choose a gel.

And some may choose a long-lasting reversible male contraceptive.

The point is having options.

Because the more choices people have, the less likely it is that one person has to carry the entire burden.

Final Thoughts

Male birth control has been talked about for years, so it is easy to roll your eyes and say, “Sure. They have been saying that forever.”

And honestly?

Fair.

But something is different now.

There are multiple approaches being investigated in human clinical trials, from a nonhormonal pill to a hormonal gel to injectable hydrogel contraception. YCT-529, ADAM and NLS-133 are all examples of researchers trying completely different ways to tackle the same problem.

We are not at the finish line.

But we are definitely closer to it.

And if male birth control eventually becomes safe, effective, reversible and accessible, it could completely change the conversation around who is responsible for preventing pregnancy.

Because maybe birth control was never supposed to be a women’s issue.

Maybe it was always supposed to be an everyone issue.

Sources

ClinicalTrials.gov. “Effects of NLS-133, a Potential Non-Hormonal ‘On-Demand’ Male Contraceptive.”

Shi R, et al. “From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha.” Journal of Medicinal Chemistry, 2026.

National Institutes of Health. “NIH to Evaluate Effectiveness of Male Contraceptive Skin Gel.”

Contraline research published in Contraception on the preclinical development of ADAM, an injectable hydrogel designed for long-lasting, nonpermanent vas-occlusive contraception.